Cutera Appoints Stephana Patton as Chief Legal Officer
2023年11月13日 - 10:30PM
ビジネスワイヤ(英語)
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a
leading provider of aesthetic and dermatology solutions, is pleased
to announce the appointment of Stephana Patton, Ph.D., J.D. as
Chief Legal Officer, effective November 13, 2023.
Dr. Patton will report directly to Taylor Harris, Cutera’s Chief
Executive Officer, and will be responsible for leading the legal,
compliance, intellectual property and human resources functions.
Dr. Patton brings over two decades of legal experience, focused on
the life sciences industry both in private practice and as in-house
counsel, to Cutera.
Taylor Harris, Chief Executive Officer, said, “I am thrilled to
welcome Stephana to the Cutera team. Stephana has built a
tremendous foundation of experience in the life science industry,
including as general counsel for three publicly traded companies,
which will serve our company well. In addition, she embodies the
core values that our team has committed to as we lead Cutera into
the next era.”
Dr. Patton said, “Cutera has a well-established leadership
position in the aesthetics industry, and I’m excited to be part of
the team that builds upon that legacy, with a focus on operational
excellence in all areas, unparalleled support of our customers, and
growth of the AviClear franchise.”
About Stephana Patton:
Stephana Patton, Ph.D., J.D. brings over twenty years of legal
experience to Cutera. She was most recently Chief Legal Officer at
InterVenn Biosciences. Prior to that, she served as General
Counsel, Corporate Secretary, and Chief Compliance Officer at Eiger
Biopharmaceuticals (NASDAQ:EIGR) where she was responsible for all
legal and compliance matters. Previously, Dr. Patton was General
Counsel, Corporate Secretary, and Chief Compliance Officer at
BioTime, Inc. and Vice President, General Counsel and Commercial
Compliance Officer at BioDelivery Sciences International, Inc. Dr.
Patton began her life sciences industry career at Salix
Pharmaceuticals, Inc., where she was Vice President of Intellectual
Property and Licensing, until the company was acquired by Valeant,
Inc. in 2015. She earned a B.S. in Chemistry from Erskine College,
a Ph.D. in Biochemistry and Cell and Developmental Biology from
Emory University, and a J.D. from Boston University School of
Law.
About Cutera, Inc.
Cutera is a leading provider of aesthetic and dermatology
solutions for practitioners worldwide. Since 1998, Cutera has been
developing innovative, easy-to-use products that harness the power
of science and nature to enable medical practitioners to offer safe
and effective treatments to their patients. For more information,
call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231113117604/en/
Cutera, Inc. Greg Barker VP, Corporate FP&A and
Investor Relations 415-657-5500 IR@cutera.com
Cutera (NASDAQ:CUTR)
過去 株価チャート
から 4 2024 まで 5 2024
Cutera (NASDAQ:CUTR)
過去 株価チャート
から 5 2023 まで 5 2024